Back to dashboard
CommercialCoverageMedium impact

08.02.12c, Epcoritamab-bysp (EPKINLY®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Apr 20, 2026
We identified it
Jun 19, 2026
Days to comply
—

Summary

Insurance policy for Epcoritamab-bysp (EPKINLY®), a pharmacy medication, has been updated with changes to medical necessity criteria and general guidelines. This affects coverage requirements for this specific drug used in oncology treatments.

Action Required

Action needed
Before April 20, 2026: Billing and clinical teams must review updated medical necessity criteria for Epcoritamab-bysp (EPKINLY®). Update prior authorization workflows and ensure documentation meets new requirements for this oncology medication. Review full policy at provided URL for specific criteria changes.

Related policy hubs